MEDST

Roche's Alzheimer's drug fails in long-awaited trial

Roche’s Alzheimer’s drug fails in long-awaited trial

Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate has not been shown to slow the progression …

Roche’s Alzheimer’s drug fails in long-awaited trial Read More »

Apple warns of falling iPhone shipments as COVID curbs Chinese factory

Apple warns of falling iPhone shipments as COVID curbs Chinese factory

Apple expects lower shipments of iPhone 14 Pro and Pro Max Apple says factory in China is operating at greatly reduced capacity Apple supplier Foxconn revises down its outlook for the fourth quarter TAIPEI, Nov 7 (Reuters) – Apple Inc (AAPL.O) expects shipments of high-end iPhone 14 models to fall from what was expected following …

Apple warns of falling iPhone shipments as COVID curbs Chinese factory Read More »

Breakingviews - Chinese investors are desperate for the bottom of the market

Breakingviews – Chinese investors are desperate for the bottom of the market

HONG KONG, Nov 2 (Reuters Breakingviews) – Tuesday’s rally in Chinese stocks may have been based on rumours. But in the offshore markets, the discount on the value offered is so extreme that it makes betting on false hopes less risky than it would otherwise be. The Hang Seng Index (.HSI) closed 5% higher on …

Breakingviews – Chinese investors are desperate for the bottom of the market Read More »

J&J buys heart pump maker Abiomed for $16.6 billion before consumer health fallout

J&J buys heart pump maker Abiomed for $16.6 billion before consumer health fallout

Nov 1 (Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday it had reached an agreement to buy heart pump maker Abiomed Inc (ABMD.O) for $16.6 billion in cash, in a bid to boost the growth of its medical devices unit after the planned spin-off of the consumer healthcare business next year. J&J agreed to …

J&J buys heart pump maker Abiomed for $16.6 billion before consumer health fallout Read More »